Target Biotech ApS: Financial statements 2024
CVR: 39676478
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Target Biotech ApS (CVR 39676478) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -25,407 and a net result of DKK 23,952,623 compared with DKK 3,926 the year before. Equity in the 2024 report amounted to DKK 24,285,415. The solvency ratio was 99.9%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -25,407
- Profit/Loss
- DKK 23,952,623
- Equity
- DKK 24,285,415
- Total Assets
- DKK 24,310,611
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -25 t. | 24 mio. | 24.3 mio. | 1 |
| 2023 | - | 64 t. | 4 t. | 333 t. | 1 |
| 2022 | - | 403 t. | 57 t. | 329 t. | 1 |
| 2021 | - | 487 t. | 88 t. | 272 t. | 1 |
| 2020 | - | 365 t. | 24 t. | 184 t. | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Target Biotech ApS has published its annual report for 2023. Gross profit came to DKK 63,828, and the net result was DKK 3,926.
About Target Biotech ApS
Target Biotech ApS is a Danish company of the type Anpartsselskab based in Allerød, founded in 2018. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Peter Horn Møller. The company is owned by Peter Horn Møller. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK -19,344 and a net result of DKK -7,028,421 compared with DKK 23,952,623 the year before. Equity in the 2025 report amounted to DKK 10,735,912.